Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial Read more about Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers. Read more about A phase 2 basket study of talabostat, a small-molecule inhibitor of dipeptidyl peptidases, administered in combination with pembrolizumab in patients with advanced solid cancers.
Rhabdomyosarcoma With EWSR1::NF2 Gene Fusion: A Case Report Potentially Expanding Its Genetic Spectrum. Read more about Rhabdomyosarcoma With EWSR1::NF2 Gene Fusion: A Case Report Potentially Expanding Its Genetic Spectrum.
Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report. Read more about Metastatic SQSTM1-NTRK1 fused non-small-cell lung cancer treated with larotrectinib and stereotactic radiosurgery resulting in durable complete response: a case report.
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial Read more about CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy Read more about NTRK Fusion–Positive Thyroid Carcinoma: From Diagnosis to Targeted Therapy
Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series. Read more about Cytologic Diagnoses of Lung Adenocarcinoma With Concomitant Metastasis From a Different Primary: A Case Series.